ReviewJournal of midwifery & women's health
Supporting Breastfeeding in the Setting of Perinatal Opioid Use Disorder.
Review in Journal of midwifery & women's health. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Studies have shown that many pregnant women with opioid use disorder intend to initiate breastfeeding after giving birth. However, continuation rates beyond the initial postpartum hospitalization are low. Achieving and maintaining an antepartum breastfeeding plan may be complicated by the unique challenges that opioid-exposed dyads experience after birth. Stigma, inconsistent messaging about the safety of breastfeeding while on opioid agonist therapy, and institutional policies that separate the dyad can contribute to low continuation rates. Additionally, neonatal opioid withdrawal syndrome may include gastrointestinal, musculoskeletal, and neurological symptoms that can lead to difficulty establishing breastfeeding. Neonatal weight loss may require temporary supplemental formula use. The safety and benefits of breastfeeding in the setting of opioid agonist treatment for perinatal opioid use disorder is well established in the literature. This case reviews the safety and benefits of breastfeeding in the setting of perinatal opioid use disorder and provides evidence-based strategies to support the feeding preferences of these families.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.